Latest Post

Why digital architecture matters to the HIV response

By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for HIV disease into the country’s newly introduced electronic medical records system. We defined success as the elimination of the backlog of data yet to be digitized so that we […]

More »

Recent Posts

Not until June 2021 does China report Wuhan wet markets sold palm civets, racoon dogs and mink from 2017-2019: Where are the SARS-CoV-2 results?

By Daniel R. Lucey MD, MPH, FIDSA Last month a paper titled “Animal sales from Wuhan wet markets immediately prior to the COVID-19 pandemic” by Xiao et al., in Nature Scientific Reports listed 18 mammalian species sold May 2017 -November 2019 in Wuhan wet markets (Table 1).  These mammalian species included masked palm civets (Paguma […]

More »

Why has no Gamma variant (P.1) been reported in Africa despite being found in 72 nations in the Americas, Asia, Europe and Australia? 

By Daniel R. Lucey MD, MPH, FIDSA Every week the World Health Organization posts an epidemiological update that includes global maps (below) and nation-by-nation listing in Annex 1 (below) for each of their four variants of concern: Alpha, Beta, Gamma, and Delta.  Multiple nations in Africa have reported Alpha, Beta, and Delta variants. In contrast, no […]

More »
More Recent Posts »

Live Blog Archive

CODEL Video

Click above for a video on our Congressional study tour to Africa, and click here to read more.

HIV

Why digital architecture matters to the HIV response

By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for […]

Tuberculosis

CDC announces publication of TB treatment trial results showing four month regimen as effective as six month

The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]

Research & Development

Can unprecedented success in COVID vaccine development boost prospects for an HIV vaccine?

By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]

Policy

As environmental destruction accelerates the spread of emerging infections, we need to talk

By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]